rs10825269
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| Make rs10825269(C;T) |
| Make rs10825269(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 10 |
| Position | 54195850 |
| Gene | PCDH15 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs10825269 |
| dbSNP (classic) | rs10825269 |
| ClinGen | rs10825269 |
| ebi | rs10825269 |
| HLI | rs10825269 |
| Exac | rs10825269 |
| Gnomad | rs10825269 |
| Varsome | rs10825269 |
| LitVar | rs10825269 |
| Map | rs10825269 |
| PheGenI | rs10825269 |
| Biobank | rs10825269 |
| 1000 genomes | rs10825269 |
| hgdp | rs10825269 |
| ensembl | rs10825269 |
| geneview | rs10825269 |
| scholar | rs10825269 |
| rs10825269 | |
| pharmgkb | rs10825269 |
| gwascentral | rs10825269 |
| openSNP | rs10825269 |
| 23andMe | rs10825269 |
| SNPshot | rs10825269 |
| SNPdbe | rs10825269 |
| MSV3d | rs10825269 |
| GWAS Ctlg | rs10825269 |
| GMAF | 0.208 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 19816713
] A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
| ClinVar | |
|---|---|
| Risk | rs10825269(T;T) |
| Alt | rs10825269(T;T) |
| Reference | Rs10825269(C;C) |
| Significance | Probable-non-pathogenic |
| Disease | not specified not provided Nonsyndromic Hearing Loss Retinitis pigmentosa-deafness syndrome |
| Variation | info |
| Gene | PCDH15 |
| CLNDBN | not specified not provided Nonsyndromic Hearing Loss, Recessive Retinitis pigmentosa-deafness syndrome |
| Reversed | 0 |
| HGVS | NC_000010.10:g.55955610C>T |
| CLNSRC | ClinVar |
| CLNACC | RCV000039695.4, RCV000086940.1, RCV000304575.1, RCV000407693.1, |
| GWAS snp | |
|---|---|
| PMID | [PMID 24797007] |
| Trait | Irritable bowel syndrome |
| Title | Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome. |
| Risk Allele | T |
| P-val | 5E-6 |
| Odds Ratio | 1.55 [1.28-1.87] |
